SCHEMBL7580249

SCHEMBL7580249

CNc1c2ccccc2nn1C

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.48
KDM4C Q9H3R0 1/20 0.48
KDM5B Q9UGL1 1/20 0.48
SLC9A1 P19634 1/20 0.41
KEAP1 Q14145 1/20 0.41
HTR3A P46098 2/20 0.38
KDM1A O60341 1/20 0.38
NUDT1 P36639 1/20 0.38
MPO P05164 5/20 0.38
SLC2A1 P11166 1/20 0.38
KDM4E B2RXH2 3/20 0.37
LMNA P02545 1/20 0.37
ELANE P08246 1/20 0.37
ATM Q13315 1/20 0.37
NCF1 P14598 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16563670 0.78 KDM5A (0.54) KDM5AKDM4CKDM5BNUDT1KDM4E
SCHEMBL147219 0.74 SLC9A1 (0.43) SLC9A1KEAP1MPOSLC2A1KDM4E
SCHEMBL2914480 0.74 MAPT (0.46) SLC9A1KEAP1HTR3ANUDT1MPO
SCHEMBL27965302 0.74 SLC9A1 (0.43) KDM5AKDM4CKDM5BSLC9A1KEAP1
SCHEMBL16215483 0.73 KDM4E (0.40) KDM4ELMNAATMSMN1; SMN2HSD17B10
SCHEMBL2673505 0.72 SLC9A1 (0.42) KDM5AKDM4CKDM5BSLC9A1KEAP1
Ammonia Solution, Strong SCHEMBL27710165 0.72 SLC9A1 (0.42) SLC9A1KEAP1MPOSLC2A1KDM4E
SCHEMBL13067164 0.72 ESR2 (0.49) SLC9A1KEAP1MPOSLC2A1KDM4E
SCHEMBL17831574 0.72 MPO (0.42) KDM5AKDM4CKDM5BSLC9A1KEAP1
SCHEMBL9721191 0.71 ADRA2A (0.48) KDM5AKDM4CKDM5BLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0904769-B1 Keratin fibre dye compositions containing Indazole amine derivatives and dyeing method OREAL (FR) 2002-09-25 EP claimed
US-6027538-A OXIDATION DYEING OF KERATINOUS FIBERS CONTAINING AT LEAST ONE COUPLER SELECTED FROM INDAZOLEAMINE DERIVATIVES AND AT LEAST ONE OXIDATION BASE; POWERFUL, NOT VERY SELECTIVE HAIR DYES WHICH ARE CAPABLE OF GENERATING INTENSE COLOR L'OREAL S.A. (FR) 2000-02-22 US claimed
US-20230203007-A1 PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS X-CHEM GLOBAL HQ 2023-06-29 US disclosed
US-6027538-A OXIDATION DYEING OF KERATINOUS FIBERS CONTAINING AT LEAST ONE COUPLER SELECTED FROM INDAZOLEAMINE DERIVATIVES AND AT LEAST ONE OXIDATION BASE; POWERFUL, NOT VERY SELECTIVE HAIR DYES WHICH ARE CAPABLE OF GENERATING INTENSE COLOR L'OREAL S.A. (FR) 2000-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203007-A1 PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS SCN1A, SCN3A, SCN2A KDM5A 1357/4885KDM4C 1690/4885KDM5B 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.